Key facts
- This page summarizes Meenu Jain's Form 4 filing for Reviv3 Procare Co (AXIL).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Apr 2023, 16:31.
Meenu Jain - 21 Apr 2023 Form 4 Insider Report for Reviv3 Procare Co (AXIL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- AXIL
- Reported as of
- 21 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Apr 2023, 16:31:12 UTC
- Prior SEC filing
- 01 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Meenu Jain
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Meenu Jain filed Form 4 for Reviv3 Procare Co (AXIL) on 25 Apr 2023.
Change
- Previous filing in this sequence was filed on 01 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVIV
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250,000
- Date
- 21 Apr 2023
- Ownership
- By Jain Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RVIV
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 300,000
- Date
- 21 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300,000
- Exercise price
- $0.2000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Meenu Jain is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Options vest as follows: 25% of the original grant amount vests on January 30, 2023 and the remainder vests in 33 equal monthly installments on the first day of each month, beginning February 1, 2023.
SEC remarks
The reporting person retired as Reviv3 Procare Company's Chief Financial Officer effective April 21, 2023. As a result, the reporting person is no longer subject to Section 16 in connection with her transactions in the equity securities of Reviv3 Procare Company and therefore will no longer report any such transactions on Form 4 or Form 5.